Study: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of Deucravacitinib (BMS-986165) in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
Seeking: Persons diagnosed with Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
PI: Dr. Naveed Sami, MD
